Brief: 9 Meters Biopharma Q4 Loss Per Share $0.04
March 23 (Reuters) - 9 Meters Biopharma Inc NMTR.O :
* Q4 LOSS PER SHARE $0.04
* 9 METERS BIOPHARMA - YEAR-ENDING CASH OF $47.0 MILLION IS
EXPECTED TO FUND ONGOING CLINICAL PROGRAMS AND BUSINESS
OPERATIONS INTO Q2 2023
Source: [ID: https://bit.ly/3iwUjbI]
Further company coverage: NMTR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 9 Meters Biopharma
See all newsIllumina cuts annual profit forecast as biotech funding woes linger (updated)
Illumina cuts annual profit forecast
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
9 Meters Biopharma falls after filing for bankruptcy protection